Literature DB >> 29883834

The value of electrochemical skin conductance measurement using Sudoscan® in the assessment of patients with familial amyloid polyneuropathy.

Jean-Pascal Lefaucheur1, Hela G Zouari2, Farida Gorram3, Tarik Nordine4, Thibaud Damy5, Violaine Planté-Bordeneuve6.   

Abstract

OBJECTIVE: To reappraise the value of electrochemical skin conductance (ESC) measurement by Sudoscan® to assess the distal involvement of small autonomic fibers in familial amyloid polyneuropathy (FAP) due to various transthyretin (TTR) mutations.
METHODS: ESC was measured at both hands and feet in 126 patients with either Val30Met (n = 65) or non-Val30Met (n = 61) TTR mutation. This series included clinically asymptomatic (n = 21) and paucisymptomatic (n = 30) patients, as well as patients with moderate (n = 37) or advanced (n = 38) TTR-FAP.
RESULTS: ESC measures did not differ between patients according to the type of TTR variant and were reduced in 24% of clinically asymptomatic patients, 40% of paucisymptomatic patients, 65% of patients with moderate TTR-FAP, and 92% of patients with advanced TTR-FAP. ESC measures were found to correlate with patients' clinical status, especially assessed by the Neuropathy Impairment Score and Karnofsky Performance Status.
CONCLUSION: ESC measures well correlate with the severity of TTR-FAP and could provide early marker of the disease. SIGNIFICANCE: ESC measures appear to be relevant to evaluate distal autonomic involvement in the context of amyloidosis.
Copyright © 2018 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Amyloidosis; Autonomic nervous system; Early marker; Skin conductance; Small fiber neuropathy; Transthyretin

Mesh:

Substances:

Year:  2018        PMID: 29883834     DOI: 10.1016/j.clinph.2018.05.005

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  8 in total

1.  Electrochemical skin conductance to measure sudomotor function: the importance of not misinterpreting the evidence.

Authors:  Aaron I Vinik; Carolina M Casellini; Henri K Parson
Journal:  Clin Auton Res       Date:  2018-09-06       Impact factor: 4.435

2.  Diagnostic utility of Sudoscan for detecting bortezomib-induced painful neuropathy: a study on 18 patients with multiple myeloma.

Authors:  Alessandro Allegra; Vincenzo Rizzo; Vanessa Innao; Angela Alibrandi; Anna Mazzeo; Rossana Leanza; Carmen Terranova; Luca Gentile; Paolo Girlanda; Andrea Gaetano Allegra; Andrea Alonci; Caterina Musolino
Journal:  Arch Med Sci       Date:  2021-01-11       Impact factor: 3.707

Review 3.  A Systematic Review and Meta-Analysis of the Prevalence of Small Fibre Impairment in Patients with Fibromyalgia.

Authors:  Eleonora Galosi; Andrea Truini; Giulia Di Stefano
Journal:  Diagnostics (Basel)       Date:  2022-05-03

Review 4.  Characteristics and natural history of autonomic involvement in hereditary ATTR amyloidosis: a systematic review.

Authors:  Alejandra Gonzalez-Duarte; Sergio I Valdés-Ferrer; Carlos Cantú-Brito
Journal:  Clin Auton Res       Date:  2019-08-31       Impact factor: 4.435

5.  Assessment of sudomotor function in hypertensive with/without type-2 diabetes patients using SUDOSCAN: An electrophysiological study.

Authors:  Ismail Ibrahim Hussein; Safaa Hussein Ali Alshammary; Marwan S M Al-Nimer
Journal:  Clin Neurophysiol Pract       Date:  2020-12-13

6.  Prevalence and prognostic value of autonomic neuropathy assessed by Sudoscan® in transthyretin wild-type cardiac amyloidosis.

Authors:  Mounira Kharoubi; Fréderic Roche; Mélanie Bézard; David Hupin; Sidney Silva; Silvia Oghina; Coraline Chalard; Amira Zaroui; Arnault Galat; Soulef Guendouz; Florence Canoui-Poitrine; Luc Hittinger; Emmanuel Teiger; Jean-Pascal Lefaucheur; Thibaud Damy
Journal:  ESC Heart Fail       Date:  2020-12-22

7.  Expert opinion on monitoring symptomatic hereditary transthyretin-mediated amyloidosis and assessment of disease progression.

Authors:  David Adams; Vincent Algalarrondo; Michael Polydefkis; Nitasha Sarswat; Michel S Slama; Jose Nativi-Nicolau
Journal:  Orphanet J Rare Dis       Date:  2021-10-03       Impact factor: 4.123

Review 8.  Diagnosis and Treatment of Hereditary Transthyretin Amyloidosis (hATTR) Polyneuropathy: Current Perspectives on Improving Patient Care.

Authors:  Marco Luigetti; Angela Romano; Andrea Di Paolantonio; Giulia Bisogni; Mario Sabatelli
Journal:  Ther Clin Risk Manag       Date:  2020-02-21       Impact factor: 2.423

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.